- Home
- ICAD vs OCX Comparison
ICAD vs OCX Comparison
Compare ICAD & OCX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ICAD
- OCX
- Stock Information
- Founded
- ICAD 1984
- OCX 2009
- Country
- ICAD United States
- OCX United States
- Employees
- ICAD N/A
- OCX N/A
- Industry
- ICAD Medical/Dental Instruments
- OCX Biotechnology: In Vitro & In Vivo Diagnostic Substances
- Sector
- ICAD Health Care
- OCX Health Care
- Exchange
- ICAD Nasdaq
- OCX Nasdaq
- Market Cap
- ICAD 40.8M
- OCX 38.7M
- IPO Year
- ICAD 1986
- OCX N/A
- Fundamental
- Price
- ICAD $1.68
- OCX $2.20
- Analyst Decision
- ICAD
- OCX Buy
- Analyst Count
- ICAD 0
- OCX 3
- Target Price
- ICAD N/A
- OCX $4.42
- AVG Volume (30 Days)
- ICAD 337.8K
- OCX 112.4K
- Earning Date
- ICAD 11-13-2024
- OCX 11-12-2024
- Dividend Yield
- ICAD N/A
- OCX N/A
- EPS Growth
- ICAD N/A
- OCX N/A
- EPS
- ICAD N/A
- OCX N/A
- Revenue
- ICAD $18,940,000.00
- OCX $709,000.00
- Revenue This Year
- ICAD $10.15
- OCX N/A
- Revenue Next Year
- ICAD $3.75
- OCX $106.34
- P/E Ratio
- ICAD N/A
- OCX N/A
- Revenue Growth
- ICAD 10.03
- OCX N/A
- 52 Week Low
- ICAD $1.18
- OCX $1.98
- 52 Week High
- ICAD $2.65
- OCX $3.82
- Technical
- Relative Strength Index (RSI)
- ICAD 43.66
- OCX 29.70
- Support Level
- ICAD $1.65
- OCX $2.33
- Resistance Level
- ICAD $2.13
- OCX $2.48
- Average True Range (ATR)
- ICAD 0.17
- OCX 0.16
- MACD
- ICAD -0.00
- OCX -0.01
- Stochastic Oscillator
- ICAD 6.12
- OCX 39.29
About ICAD iCAD Inc.
icad Inc is a medical technology company providing cancer detection and therapy solutions. The Company operates in one segment: Detection. The Detection segment include advanced image analysis and workflow solutions that enable healthcare professionals to serve patients by identifying pathologies, comprehensive range of high-performance, Artificial Intelligence and Computer-Aided Detection (CAD) systems and workflow solutions for 2D and 3D mammography, Magnetic Resonance Imaging and Computed Tomography. The company geographically operates in France, Belgium, Italy, Germany, Switzerland and All other.
About OCX Oncocyte Corporation
OncoCyte Corp focuses on the discovery, development, and commercialization of novel, non-invasive, liquid biopsy diagnostics for the early detection of cancer. The company develops diagnostic tests based on liquid biopsies using blood or urine samples for detecting lung, bladder, and breast cancers. In addition, it also develops screening diagnostics as potential replacements for screening imaging procedures that do not meet the needs of patients, health care providers or payers.